Publications & Works

Publication Network
Articles 8
All (8)
SCI-E, SSCI, AHCI (8)
SCI-E, SSCI, AHCI, ESCI (8)
Scopus (8)

1. Mitochondria targeted hydrogen sulfide donor AP39 attenuates allergic airway inflammation and airway hyperreactivity in mouse

Altiparmak B., KARAMAN Y., KURTULAN O., ÖNDER S. Ç., BOZKURT T. E.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY , vol.339, 2026 (SCI-Expanded, Scopus) identifier identifier

2. Endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine ameliorates lipopolysaccharide-induced airway inflammation and bronchial hyperreactivity in mice

KARAMAN Y., Kaya-Yasar Y., ÖNDER S. Ç., BOZKURT T. E., Sahin-Erdemli I.
JOURNAL OF PHARMACY AND PHARMACOLOGY , 2025 (SCI-Expanded, Scopus) identifier identifier

3. Endocannabinoids suppress inflammation-induced tumor necrosis factor alpha up- regulation in human and Guinea-pig lungs

Abohalaka R., KARAMAN Y., UYSAL S., DİKMEN E., BOZKURT T. E.
EUROPEAN RESPIRATORY JOURNAL , 2024 (SCI-Expanded, Scopus) identifier

4. Metabolomic analysis of the effect of endocannabinoid metabolism inhibition in allergic airway inflammation

Abohalaka R., KARAMAN Y., REÇBER T., ÖNDER S. Ç., NEMUTLU E., BOZKURT T. E.
EUROPEAN RESPIRATORY JOURNAL , 2024 (SCI-Expanded, Scopus) identifier

5. The effect of mitochondria-targeted slow hydrogen sulfide releasing donor AP39-treatment on airway inflammation

KARAMAN Y., Kaya-Yasar Y., Eylem C. C., ÖNDER S. Ç., NEMUTLU E., BOZKURT T. E., et al.
European Journal of Pharmacology , vol.946, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

6. Endocannabinoid metabolism inhibition ameliorates ovalbumin-induced allergic airway inflammation and hyperreactivity in Guinea pigs

Abohalaka R., KARAMAN Y., REÇBER T., ÖNDER S. Ç., NEMUTLU E., BOZKURT T. E.
LIFE SCIENCES , vol.306, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

7. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice

Karaman Y., Kaya-Yasar Y., BOZKURT T. E., Sahin-Erdemli I.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.128, no.5, pp.652-660, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

8. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice

Kaya-Yasar Y., Karaman Y., Bozkurt T. E., Önder S. Ç., Sahin-Erdemli I.
PULMONARY PHARMACOLOGY & THERAPEUTICS , vol.45, pp.170-180, 2017 (SCI-Expanded, Scopus) identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 2

1. Intranasal treatment with hydrogen sulfide releasing donors can prevent bleomycin-induced pulmonary fibrosis in mice

Karaman Y., Büber E., Kurtulan O., Abohalaka R., Şahan Ö. B., Önder S. Ç., et al.
The ERS Congress 2024 , Vienna, Austria, 7 - 11 September 2024, vol.64, no.352, pp.352, (Summary Text)

2. PRIMING BONE MARROW MESENCHYMAL STEM CELLS WITH HEPATOCYTE GROWTH FACTOR (HGF-MSC) AMELIORATES BLEOMYCİN-INDUCED PULMONARY FIBROSIS IN MICE

Şahan Ö. B., Karaman Y., Büber E., Kurtulan O., Abohalaka R., Önder S. Ç., et al.
ISSCR 2024, Hamburg, Germany, 10 - 13 July 2024, pp.660, (Summary Text)
Metrics

Publication

17

Publication (WoS)

10

Publication (Scopus)

8

Citation (WoS)

39

H-Index (WoS)

3

Citation (Scholar)

54

H-Index (Scholar)

4

Project

6